statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Futures Drop Ahead Of CPI, FOMC; Euro Slumps After Weekend Election Shock

Futures Drop Ahead Of CPI, FOMC; Euro Slumps After Weekend Election Shock

 US equities were poised for modest losses to start the week after underlying indexes hit a new all time high on...

ProKidney appoints Ulrich Ernst as EVP, technical operations

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations

Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufacturing of cell therapies Mr. Lucio Tozzi joined in...

ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights

WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ( ProKidney or the Company"), a leading late clinical-stage cellular therapeutics company focused on chronic...

ProKidney (NASDAQ:PROK) Research Coverage Started at Morgan Stanley

Morgan Stanley initiated coverage on shares of ProKidney (NASDAQ:PROK  Free Report) in a research note issued to investors on Thursday, Marketbeat reports. The brokerage issued an equal weight...

ProKidney assumed with an Equal Weight at Morgan Stanley

ProKidney to Participate in Jefferies Biotech on the Bay Summit

WINSTON-SALEM, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ( ProKidney ), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease...

Head to Head Comparison: ProKidney (NASDAQ:PROK) vs. Cabaletta Bio (NASDAQ:CABA)

ProKidney (NASDAQ:PROK  Get Free Report) and Cabaletta Bio (NASDAQ:CABA  Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the...

ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.

Volume	716,010.00
52-Wk High	$13.51
52-Wk Low	$1.12

PROK ProKidney Corp

About

Feed

News

Sentiment

Earnings

Fundamentals